Navigation Links
IntegriChain® Announces Release of DNA 2.0
Date:6/12/2012

PRINCETON, N.J., June 12, 2012 /PRNewswire/ -- IntegriChain, Inc., the developer of the DNA channel data and application cloud, announced today the release of DNA 2.0.  As the latest version of the company's flagship product, DNA 2.0 provides customers a next-generation suite of interactive analytics, point-of-sale reporting and real-time demand sensing.

(Logo: http://photos.prnewswire.com/prnh/20111130/NY15137LOGO )

Channel visibility is a major focus of the DNA 2.0 release, enabling users to access factory sales, wholesale inventory, retail inventory, retail stocking and point-of-sale purchases in a single integrated reporting and analytics tool.  Another enhancement provides users with real-time email notifications and exception dashboards for a growing range of order, distributor, and downstream channel metrics.

DNA 2.0 also includes major enhancements to the DNA cloud's infrastructure, greatly boosting speed and flexibility.  With the implementation of InfoBright® (a columnar database technology), and Dell™ Everest servers (which contain Intel®'s next-generation of processors), DNA 2.0 users can request, pivot and report on millions of channel data records in seconds.

Kevin Leininger, CEO of IntegriChain, stated, "Pre-canned reports are simply too limiting.  Healthcare manufacturers are more and more analytical.  They need to access their channel data in a way that is flexible and scales across large portfolios of SKUs and hundreds of thousands of points of sale.  DNA users can pull years of detailed inventory and distribution sales data in seconds, and spin and drill into this data without advanced technical knowledge."

DNA 2.0 also includes the industry's most robust process for detecting and investigating accuracy and completeness issues in EDI 852 and EDI 867 data — including real-time monitoring of inventory and sales data validity, file timeliness, and file completeness.

"DNA 2.0 is the first system to fully realize our customers' vision for complete, timely visibility to the forward channel," added Josh Halpern, IntegriChain VP of Marketing.  "By raising the industry standard for data quality, system performance, and ease of use, DNA is helping more and more manufacturers to put channel data at the heart of their customer and operational strategies."

About IntegriChain
IntegriChain, Inc. is the developer of DNA, the leading enterprise cloud for real-time channel data and analytic applications.  DNA data and apps provide manufacturers 100% visibility to their forward channels with unprecedented ease of use, speed and transparency.  DNA's end-to-end platform and self-service analytics eliminate the IT bottleneck between business users and their data, thereby accelerating enterprise decision-making.  Located in Princeton, New Jersey, IntegriChain has been recognized on both the Inc 500 and the Red Herring 100 lists of America's Fastest Growing Companies, and is nineteenth on the Forbes 2011 list of America's Most Promising Companies. For more information, please visit www.integrichain.com

All names referred to are trademarks or registered trademarks of their respective owners.

Contact: Ally Hanlon
IntegriChain, Inc.
Phone: 609.986.2004
Fax: 609.806.5006
info@integrichain.com


'/>"/>
SOURCE IntegriChain, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American HealthTech Announces Streamlined Connectivity With LTC Trend Tracker
2. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
3. Law Office of Brodsky & Smith, LLC Announces Investigation of SRI Surgical Express, Inc.
4. Forum Extended Care Services Announces Plans to Move to Larger, State-Of-the-art Facility
5. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
6. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
7. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
8. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
9. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
10. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
11. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):